Delayed Diagnosis of Buried Bumper Syndrome When Only the Jejunostomy Extension is Used in a Percutaneous Endoscopic Gastrostomy-jejunostomy Levodopa-carbidopa Intestinal Gel Delivery System.

buried bumper syndrome carbidopa-levodopa drug delivery systems gastrostomy infusion pumps parkinson disease peg-j complication

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
30 Apr 2019
Historique:
entrez: 9 7 2019
pubmed: 10 7 2019
medline: 10 7 2019
Statut: epublish

Résumé

Direct intrajejunal levodopa-carbidopa intestinal gel (LCIG) administered through a percutaneous endoscopic gastrostomy (PEG) with a jejunal extension tube (PEG-J) is an FDA-approved modality for treatment of patients with advanced Parkinson's disease (PD). Buried bumper syndrome (BBS) is a rare complication associated with PEG tubes inserted for drug administration or enteral feeding. The syndrome is diagnosed endoscopically revealing burial of the internal bumper in the gastric wall, causing numerous serious complications. When only the J extension of a PEG-J is used to deliver medications, and the G tube is not utilized, a delay in the diagnosis of BBS can occur. This is likely as the small caliber J extension tube remains patent and functional. We present the case of an elderly patient with advanced PD on LCIG therapy, who presented with a dislodged J-tube from a PEG-J system. Endoscopy revealed BBS that had likely developed prior to dislodgment of J-extension and despite a conservative approach, the internal bumper needed to be surgically extracted to prevent further complications.

Identifiants

pubmed: 31281751
doi: 10.7759/cureus.4568
pmc: PMC6605971
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e4568

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Neuropharmacol. 2008 Mar-Apr;31(2):63-73
pubmed: 18382177
Nutr Clin Pract. 2008 Jun-Jul;23(3):322-4
pubmed: 18595866
Mov Disord. 2009 May 15;24(7):993-1000
pubmed: 19253412
Z Gastroenterol. 2009 Nov;47(11):1145-8
pubmed: 19899022
Pract Neurol. 2013 Jun;13(3):140-52
pubmed: 23487815
World J Gastroenterol. 2014 Jul 14;20(26):8505-24
pubmed: 25024606
Gastrointest Endosc Clin N Am. 2015 Jan;25(1):71-82
pubmed: 25442959
Mov Disord. 2015 Apr;30(4):500-9
pubmed: 25545465
Expert Opin Pharmacother. 2015;16(18):2807-17
pubmed: 26595228
World J Gastroenterol. 2016 Jan 14;22(2):618-27
pubmed: 26811611
Clin Transl Gastroenterol. 2016 Mar 31;7:e159
pubmed: 27030949
Brain Behav. 2017 Jun 05;7(7):e00737
pubmed: 28729942
Gastroenterol Clin North Am. 2018 Mar;47(1):23-37
pubmed: 29413015

Auteurs

Ahmad A Abu-Heija (AA)

Internal Medicine, Wayne State University, Detroit Medical Center, Detroit, USA.

Maher Tama (M)

Gastroenterology, Wayne State University, Detroit Medical Center, Detroit, USA.

Usama Abu-Heija (U)

Miscellaneous, Jordan University of Science and Technology, Amman, JOR.

Mowyad Khalid (M)

Internal Medicine, Wayne State University, Detroit Medical Center, Detroit, USA.

Omar Al-Subee (O)

Gastroenterology, McLaren Hospital, Flint, USA.

Classifications MeSH